Clinical Trials Browser

Phase 2 × Melanoma × Imiquimod × Clear all

NCT00273910 2012-10-19

Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma

Phase 2 Completed

104 enrolled 12 charts

Melanoma

NCT00651703 2010-11-15

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Phase 2 Completed

Melanoma